Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 11096-11105

  Finnegan, C M ^a   Berg, W ^a   Lewis, G K ^a   DeVico, A L ^a  

^a INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD24 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DYE; EPITOPE; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANTIGENICITY; ARTICLE; BINDING AFFINITY; CELL FUSION; COCULTURE; COMPLEX FORMATION; CONTROLLED STUDY; COOLING; COVALENT BOND; CROSS LINKING; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN STRUCTURE; STAINING; SYNCYTIUM; TEMPERATURE; VIRUS ENVELOPE;

AIDS VACCINES; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; BINDING SITES; CELL FUSION; CELL LINE; HIV; HIV ENVELOPE PROTEIN GP120; HUMANS; RECEPTORS, CXCR4;

EID: 0034759248     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.11096-11105.2001     Document Type: Article

References (35)

1. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1
2. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
3. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure
4. HIV entry and its inhibition
5. Covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor elicit a neutralizing immune response that includes antibodies selective for primary virus isolates
6. Monoclonal antibodies against covalently cross-linked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp120
7. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies
8. HIV-1 entry cofactor: Functional cDNA cloning of a seven transmembrane, G proteincoupled receptor
9. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
10. Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1
11. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120
12. Characterization of CD4gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation
13. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein
14. 2+, and cytochalasin on fusion activity mediated by human immunodeficiency virus type 1 and type 2 glycoproteins
15. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene
16. Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1
17. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV
18. Enhancement of human immunodeficiency virus type 1 envelope-mediated fusion by a CD4-gp120 complex-specific monoclonal antibody
19. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
20. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies
21. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
22. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
23. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: Soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120
24. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer
25. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: Consequences for virus entry and neutralization
26. Spontaneous and ligand-induced trafficking of CXC-chemokine receptor 4
27. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralising epitopes exposed on gpl20-CD4 binding
28. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
29. Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay
30. Atomic structure of the ectodomain from HIV-1 gp41
31. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor
32. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
33. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
34. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein
35. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gpl20 epitopes induced by receptor binding